We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$282M
AUM Growth
-$3.93M
Cap. Flow
-$6.27M
Cap. Flow %
-2.23%
Top 10 Hldgs %
46%
Holding
230
New
13
Increased
66
Reduced
108
Closed
18

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$844K
2
EXP icon
Eagle Materials
EXP
+$808K
3
NVDA icon
NVIDIA
NVDA
+$712K
4
PI icon
Impinj
PI
+$675K
5
AAPL icon
Apple
AAPL
+$650K

Sector Composition

Rank Sector Weight
1 Technology 29.06%
2 Healthcare 15.37%
3 Communication Services 8.73%
4 Financials 7.38%
5 Consumer Discretionary 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
76
Amgen
AMGN
$201B
$709K 0.25%
2,719
+9
+0.3% +$2.67K
VST icon
77
Vistra
VST
$51.4B
$694K 0.25%
5,035
+1,335
+36% +$185K
PCT icon
78
PureCycle Technologies
PCT
$1.22B
$668K 0.24%
65,200
-28,000
-30% -$325K
MO icon
79
Altria Group
MO
$122B
$663K 0.24%
12,675
+325
+3% +$17.3K
VXUS icon
80
Vanguard Total International Stock ETF
VXUS
$153B
$661K 0.23%
11,215
-975
-8% -$60.4K
BND icon
81
Vanguard Total Bond Market
BND
$159B
$641K 0.23%
8,909
-832
-9% -$60.8K
AMD icon
82
Advanced Micro Devices
AMD
$817B
$640K 0.23%
5,299
-4,120
-44% -$593K
RTX icon
83
RTX Corp
RTX
$262B
$639K 0.23%
5,523
-1,065
-16% -$129K
VGT icon
84
Vanguard Information Technology ETF
VGT
$139B
$639K 0.23%
8,216
-48
-0.6% -$3.69K
XLP icon
85
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$634K 0.23%
8,065
+192
+2% +$15.6K
C icon
86
Citigroup
C
$221B
$630K 0.22%
8,950
+100
+1% +$6.74K
BST icon
87
BlackRock Science and Technology Trust
BST
$1.6B
$625K 0.22%
17,098
-158
-0.9% -$5.8K
VNQ icon
88
Vanguard Real Estate ETF
VNQ
$39.6B
$620K 0.22%
6,960
+80
+1% +$7.56K
SBCF icon
89
Seacoast Banking Corp of Florida
SBCF
$3.34B
$619K 0.22%
22,500
-3,050
-12% -$85.9K
HUMA icon
90
Humacyte
HUMA
$178M
$613K 0.22%
121,400
+57,200
+89% +$283K
AMAT icon
91
Applied Materials
AMAT
$445B
$610K 0.22%
3,750
XHB icon
92
State Street SPDR S&P Homebuilders ETF
XHB
$2.08B
$608K 0.22%
5,821
-273
-4% -$32K
AMLP icon
93
Alerian MLP ETF
AMLP
$12.7B
$603K 0.21%
12,515
-340
-3% -$16.3K
PLTR icon
94
Palantir
PLTR
$322B
$583K 0.21%
+7,714
New +$449K
CMCSA icon
95
Comcast
CMCSA
$86.1B
$574K 0.2%
15,285
-971
-6% -$40.3K
ETV
96
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.75B
$551K 0.2%
38,244
-2,936
-7% -$41.4K
IXUS icon
97
iShares Core MSCI Total International Stock ETF
IXUS
$57.4B
$549K 0.2%
8,306
-39
-0.5% -$2.71K
STT icon
98
State Street
STT
$51.4B
$545K 0.19%
5,554
MODL icon
99
VictoryShares WestEnd US Sector ETF
MODL
$1.03B
$540K 0.19%
13,430
-30
-0.2% -$1.21K
EOS
100
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$537K 0.19%
22,402
+39
+0.2% +$897

Similar funds

Wealth Effects's Q4 2024 Portfolio in Review

As of Q4 2024, Wealth Effects held 230 positions worth $282M, down 1.4% from $285M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Wealth Effects's Q4 2024 filing shows 13 new, 66 increased, 108 reduced and 18 closed positions. Its largest new stake was Palantir: 7,714 shares worth $583K. The largest sale was Novo Nordisk, an estimated $844K.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.

  • Wealth Effects's largest Q4 2024 buy was Palantir: 7,714 shares worth $583K.
  • Wealth Effects added most to Avadel Pharmaceuticals in Q4 2024, an estimated $1.34M increase.
  • Wealth Effects's biggest Q4 2024 reduction was Eagle Materials, cutting an estimated $808K.
  • Wealth Effects fully exited Novo Nordisk in Q4 2024, selling an estimated $844K.
  • Wealth Effects's ten largest holdings make up 46% of its $282M portfolio in Q4 2024.
  • Wealth Effects opened 13 new positions and closed 18 in Q4 2024.
  • Wealth Effects's portfolio value fell 1.4% quarter-over-quarter to $282M.

Based on Wealth Effects's 13F filing for Q4 2024, filed 22 Jan 2025.